Adipose-derived mesenchymal stromal cells promote an exhaustion-associated phenotype in T cells through TIM-3 upregulation independent of PD-1.
Mirshafiei S., Absalan F., Yousefi B., Shariat M., Talei AR., Baharlou R.
Prospective Study on Immune Modulation, published in Discov Oncol (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Discov Oncol (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42053930
- PMCID
- PMC13269619
- DOI
- 10.1007/s12672-026-05116-8
Abstract (original English)
Adipose-derived mesenchymal stromal cells (ASCs) are important components of the breast tumor microenvironment (TME) with hemostatic features and immunomodulatory abilities that can either inhibit or promote tumor growth through direct cell-cell contact or the secretion of biomolecules. This study aimed to investigate the effects of ASCs on PD-1 and/or TIM-3 expression by T cells isolated from breast tumor-draining lymph nodes (TDLNs). Lymphocytes were isolated from fresh, uninvolved axillary lymph nodes and cultured either directly with ASCs from the breast adipose tissue of healthy women (N.ASCs) or breast cancer patients (C.ASCs), or in conditioned media (CM) from these ASCs. After 48 and 72 h, the expression of PD-1 and/or TIM-3 on CD3 + , CD4 + , and CD8 + T cells was analyzed using flow cytometry. Results showed that direct co-culture with both N.ASCs and C.ASCs significantly increased the frequency of CD3 + , CD3 + CD4 + , and CD3 + CD8 + T cells expressing the exhaustion marker TIM-3 in both 48- and 72-hour cultures. This increase was independent of PD-1 expression, as both TIM-3 + PD-1 + and TIM-3 + PD-1 - T cell populations increased significantly. Interestingly, the frequency of T cell populations that expressed PD-1 without TIM-3 remained unchanged. Furthermore, culturing lymphocytes in CM of ASCs had no significant impact on the frequency of TIM-3- and/or PD-1-expr
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol